Published in Diabetes Obes Metab on January 14, 2008
The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol Rev (2008) 2.73
Protection of exendin-4 analogue in early experimental diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2008) 0.98
Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control. Diabetes Care (2009) 0.92
Activation of the GLP-1 receptor signalling pathway: a relevant strategy to repair a deficient beta-cell mass. Exp Diabetes Res (2011) 0.91
Epac2-dependent rap1 activation and the control of islet insulin secretion by glucagon-like peptide-1. Vitam Horm (2010) 0.91
High dosage of Exendin-4 increased early insulin secretion in differentiated beta cells from mouse embryonic stem cells. Acta Pharmacol Sin (2010) 0.81
Longer-Term Physiological and Metabolic Effects of Gastric Bypass Surgery. Curr Diab Rep (2016) 0.77
Exenatide: a new promising antidiabetic agent. Indian J Pharm Sci (2010) 0.75
Exendin-4 antagonizes Aβ1-42-induced attenuation of spatial learning and memory ability. Exp Ther Med (2016) 0.75
Exenatide Treatment Alone Improves β-Cell Function in a Canine Model of Pre-Diabetes. PLoS One (2016) 0.75
Mitochondrial control of nuclear apoptosis. J Exp Med (1996) 5.01
Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med (1995) 4.88
Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med (1995) 4.20
Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med (1996) 4.00
Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant (2007) 3.26
Insulin independence after islet transplantation into type I diabetic patient. Diabetes (1990) 2.57
The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients. Diabetologia (2007) 2.48
The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia. Diabetes Obes Metab (2012) 2.44
Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials. Diabetes Obes Metab (2012) 2.23
Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia (2009) 2.17
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia (2008) 2.15
Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med (2005) 2.10
High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes (2001) 2.02
Use of octogenarian donors for liver transplantation: a survival analysis. Am J Transplant (2014) 2.00
Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial. Surgery (1995) 1.99
Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients. Transplantation (1991) 1.98
Serum haptoglobin: a novel marker of adiposity in humans. J Clin Endocrinol Metab (2004) 1.94
Thrombosis in the portal venous system after elective laparoscopic splenectomy. Surg Endosc (2004) 1.92
Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol (2004) 1.88
Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers. Blood (1995) 1.83
Obesity and insulin resistance in humans: a dose-response study. Metabolism (1990) 1.74
Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia (2005) 1.71
A telemedicine support for diabetes management: the T-IDDM project. Comput Methods Programs Biomed (2002) 1.69
Per-arnt-sim (PAS) domain-containing protein kinase is downregulated in human islets in type 2 diabetes and regulates glucagon secretion. Diabetologia (2010) 1.67
Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J Immunol (1996) 1.64
Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. Diabetologia (2012) 1.63
Grasping and dissecting instrument for hand-assisted laparoscopic surgery: development and early clinical experience. Surg Endosc (2002) 1.62
Evaluation of an uncalibrated arterial pulse contour cardiac output monitoring system in cirrhotic patients undergoing liver surgery. Br J Anaesth (2009) 1.61
Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett (1996) 1.58
Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients. Eur J Clin Invest (2001) 1.54
The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene (1997) 1.53
High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: a randomized controlled study. Clin Pharmacol Ther (2011) 1.52
Bullet emboli to the systemic and venous circulation. Surgery (1990) 1.50
Lipomas of the large bowel. Eur J Surg (1996) 1.49
Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes. Diabetologia (2010) 1.48
Prevalence and risk factors of extrapancreatic malignancies in a large cohort of patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Oncol (2013) 1.47
Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes (1996) 1.46
In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med (2008) 1.46
Anorectal malformations and neurospinal dysraphism: is this association a major risk for continence? Pediatr Surg Int (2010) 1.46
Neonatal lupus: fetal myocarditis progressing to atrioventricular block in triplets. Lupus (2003) 1.45
[New therapeutic approachs in melanoma]. Rev Med Brux (2004) 1.40
Molecular analysis of V(H)I+ B lymphocytes in hepatitis C patients. Dig Liver Dis (2003) 1.40
Multi-detector computed tomography angiography of the hepatic artery in liver transplant recipients. Acta Radiol (2005) 1.39
Fasting hyperglycaemia following trans-catheter arterial chemo-embolization for hepatocellular carcinoma in cirrhosis. Ital J Gastroenterol Hepatol (1997) 1.39
Islet inflammation and CXCL10 in recent-onset type 1 diabetes. Clin Exp Immunol (2010) 1.38
[Rational and selective management of patients with anterior urethral stricture disease]. Actas Urol Esp (2011) 1.38
Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev (2003) 1.37
Listeriosis in 225 non-pregnant patients in 1992: clinical aspects and outcome in relation to predisposing conditions. Scand J Infect Dis (1996) 1.37
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets. Diabetologia (2012) 1.35
Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents. Anticancer Res (2009) 1.34
Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. J Clin Invest (1993) 1.34
Patterns of genomic instability in gastric cancer: clinical implications and perspectives. Ann Oncol (2006) 1.33
Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res (1997) 1.30
Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo. Eur J Immunol (1995) 1.29
Glucose- and arginine-induced insulin secretion by human pancreatic beta-cells: the role of HERG K(+) channels in firing and release. FASEB J (2000) 1.28
Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes (1999) 1.28
Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Res Clin Pract (2003) 1.27
Management and follow-up of 78 giant haemangiomas of the liver. Br J Surg (1996) 1.26
Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology (1999) 1.25
Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma. Surgery (1997) 1.24
Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans. Exp Brain Res (1996) 1.24
PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. Exp Cell Res (1998) 1.23
Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437. Oncogene (2001) 1.22
Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia (2007) 1.21
Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am J Respir Crit Care Med (2001) 1.20
Studies on the positive inotropic effect of phenylephrine: a comparison with isoprenaline. Br J Pharmacol (1975) 1.20
Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma. Ann Oncol (2013) 1.20
Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV). Neurology (2004) 1.19
Detection of biliary complications after orthotopic liver transplantation with MR cholangiography. Magn Reson Imaging (2001) 1.17
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. Diabetes Metab (2007) 1.17
Elevated hydroperoxide levels and antioxidant patterns in Papillon-Lefèvre syndrome. J Periodontol (2001) 1.15
The metabolic syndrome is related to albuminuria in Type 2 diabetes. Diabet Med (2008) 1.14
FIRI: fasting or false insulin resistance index? Lancet (1996) 1.13
Technical review of the da Vinci surgical telemanipulator. Int J Med Robot (2012) 1.13
Long-acting depot lanreotide in the treatment of patients with advanced neuroendocrine tumors. Am J Clin Oncol (2000) 1.12
BioEnterics intragastric balloon for treatment of morbid obesity in Prader-Willi syndrome: specific risks and benefits. Obes Surg (2008) 1.12
Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance. Diabetologia (2003) 1.12